Obesity Strategy

Aniket Pujari September 14, 2026

Novo Rebrands and Refines Global Strategy as Race for Obesity Market Dominance Escalates

Novo Nordisk unveils a major corporate rebranding to Novo as CEO Mike Doustdar outlines a revised obesity strategy to address rising competition from Eli Lilly.

Novo Rebrands and Refines Global Strategy as Race for Obesity Market Dominance Escalates

You Missed

Bank of America Warns of Q3 Investment Banking Fee Drop as AI Market Boom Slows

Novo Rebrands and Refines Global Strategy as Race for Obesity Market Dominance Escalates

General Motors Accelerates U.S. Battery Supply Chain Strategy Amid Growing Geopolitical Scrutiny

25 Years After 9/11: U.S. Begins Rolling Back Legacy Airport Security Restrictions